“One Less” Market – “One More” New Market: Over-50s still face cervical cancer risk

Let’s see how these 50 – 60 year old women who bucked HRT feel about the HPV vaccine.

The reality is though that as women age, our immune system becomes weakened – making us more vulnerable to viruses.  Such is the case with HPV.  Clear pap tests 10 years ago, may not equate to the same result today. Also more women over 50 ae having unprotected sex – and with more partners if they are single (or not!).  Seriously, though consider strenghthening your immune system – to ward off any viral infection. And use condoms! Leslie

Cancer Research UK

May 11, 2009

A new study published by the Institute of Cancer Research (ICR) has provided support for continuing cervical screening beyond the age of 50.

In England, women are invited for cervical screening every three years between the ages of 25 and 49, and every five years between the ages of 50 and 64.

The reduced frequency of screening among over-50s reflects the fact that cervical cancer becomes slightly less common in this age group and some experts have even suggested that the upper age limit for the NHS Cervical Cancer Screening programme should be lowered.

However, the latest study in the British Journal of Cancer found that screening continues to identify abnormalities in over-50s, even if the screening tests they had in their 40s came back clear.

The researchers studied a group of 57,000 older women, all of whom had at least two negative screening tests in their 40s and a further test over the age of 50 between 1988 and 2003.

Lead author Dr Roger Blanks revealed that nearly two thirds of serious pre-cancerous ‘CIN 3’ abnormalities currently detected in over-50s would be undetected if screening for this age group was halted.


Another Comment –
Just thought about this – interesting to administer the HPV vaccine to young girls with unstable and unreliable hormone cycles and women in their 50’s going into or already in menopause – with unstable and unreliable hormone cycles. It seems to me that the risks for avderse reactions might be higher at both ends of this spectrum.


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.